Pfizer Inc. holds a Federal Supply Schedule (FSS-61-IB) contract with the U.S. General Services Administration to provide pharmaceuticals and drugs to federal agencies. This $6.25 billion multiple-award contract enables Pfizer to deliver a wide range of pharmaceutical products, including controlled substances, antibiotics, vaccines, and other medications, to support the healthcare needs of federal customers such as the Department of Defense, Department of Veterans Affairs, and Centers for Disease Control and Prevention.
Under this contract, Pfizer fulfills firm fixed-price delivery orders to supply COVID-19 vaccines, routine adult immunizations, and specialized drugs like Oxybryta for sickle cell disease treatment across various federal healthcare programs. Pfizer also holds indefinite-delivery, indefinite-quantity contracts with the CDC to provide pediatric and adult vaccines, supporting nationwide immunization initiatives. These contract vehicles allow federal agencies to flexibly access Pfizer's pharmaceutical products and services as needed, without major subcontractors or set-aside designations, to enhance combat readiness, veteran care, and public health.
Generated 6/12/24, 9:11 AM